Lantheus Holdings, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 100.32 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.55B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked o...